Christy Boone shows Billy Shallcross, Ruth Shallcross and fourth-grader Sierra Shallcross how a 3D printer works during presentations Friday at Middlesettlements Elementary School featuring science, technology, engineering, art and mathematics. Brody Webb, a first grade student at Middlesettlements Elementary, tries to levitate a ping-pong ball by blowing through a straw during Friday’s STEAM Night.
Category: Healthcare Industry
Invivoscribe Expands Ion PGM(TM) NGS Platform Menu: Releases…
Invivoscribe Technologies Inc., a global company with more than 20 years of experience providing clonality and biomarker test solutions for the fields of oncology, personalized molecular diagnostics and personalized molecular medicine , today released three additional CE-marked next-generation sequencing assay kits for in vitro diagnostic use to assist in the diagnosis of B-cell malignancies. Invivoscribe has now commercialized more than 40 CE-IVD assays and bioinformatics packages for capillary electrophoresis and NGS platforms and has recently announced a long-term agreement with Thermo Fisher Scientific to bring regulated IVD assays through the FDA on the Ion PGM Dx System.
Novavax Reports Fourth Quarter and Year-End 2016 Financial Results
Novavax, Inc., today announced its financial results for the fourth quarter and twelve months ended December 31, 2016. Continued execution of the global Phase 3 PrepareTM clinical trial to prevent RSV in infants via maternal immunization.
Life Technologies Corp. v. Promega Corp. and the Absent Presumption Against Extraterritoriality
Guest Post by Tim Holbrook, Professor of Law at Emory University School of Law. Professor Holbrook has written extensively on the extraterritorial application of U.S. patent law.
3 Stocks That Are Ridiculously Cheap Right Now
With our stock market trading near all-time highs today, it might seem crazy to put new investing dollars to work right now. But for value-oriented investors who know where to look, there are always enticing deals to be found.
Press release distribution, EDGAR filing, XBRL, regulatory filings
For the fourth quarter of 2016, Green Dot reported GA… )–Cloud Peak Energy Inc. announced that it has commenced a registered underwritten public offering of 13,500,000 shares of its common stock.
Short Interest in Novavax, Inc. (NVAX) Decreases By 1.9%
Novavax, Inc. was the recipient of a significant drop in short interest in the month of January. As of January 31st, there was short interest totalling 63,797,973 shares, a drop of 1.9% from the January 13th total of 65,010,684 shares.
Jacqueline Kennedy to British lord she rejected: I love you like a brother
Jaqueline Kennedy Onassis, embracing her daughter, Caroline Kennedy, and her new husband, Greek shipping magnate Aristotle Onassis aboard the yacht, Christina, shortly after their wedding in Greece on October 21, 1968. Widowed first lady Jacqueline Kennedy had at least one serious alternative to marrying Greek shipping tycoon Aristotle Onassis in October 1968: a British lord and former ambassador to Washington who had been one of John F. Kennedy’s closest friends, according to the New York Times .
Neogen Corporation (NEOG) Stake Held by Bamco Inc. NY
Bamco Inc. NY continued to hold its position in shares of Neogen Corporation during the third quarter, Holdings Channel reports. The institutional investor owned 444,596 shares of the company’s stock at the end of the third quarter.
New study uncovers important links between glioblastoma and epileptic seizures
Detecting brain tumors at the earliest possible stage and eliminating them before seizures begin might be possible one day, according to research by scientists at Baylor College of Medicine and Texas Children’s Hospital. In the study, which is published in the journal Nature Neuroscience , the scientists report that the emergence of specific brain cells during brain tumor progression in a mouse model marked the onset of seizures and brain tumor invasion.
HEALTH: How Samsung is leveraging VR to manage pain. Together, …
Together, Samsung and AppliedVR are working with a group of hospitals to validate the technology for children and adults. In one randomized controlled trial, the two have collaborated with Cedars-Sinai Medical Center to evaluate the clinical utility of VR for inpatient pain management and its effect on narcotic use, length of stay, and patient satisfaction.
Research consortium awarded $21 million NIH grant to find ways to…
An international consortium of academic research institutions have been awarded a $21 million grant from the National Institutes of Health to develop better ways to prevent epilepsy in patients who have suffered traumatic brain injuries. The grant will be led by seven principal investigators at five institutions: Albert Einstein College of Medicine, David Geffen School of Medicine at UCLA, Keck School of Medicine at the University of Southern California, University of Melbourne and University of Eastern Finland.
Web-connected medical devices are great. Unless . . .
Web-connected medical devices are great. Unless . . . There are many benefits to having Internet-connected medical devices.
Stem cell secretions may protect against glaucoma
A new study in rats shows that stem cell secretions, called exosomes, appear to protect cells in the retina, the light-sensitive tissue in the back of the eye. The findings, published in Stem Cells Translational Medicine , point to potential therapies for glaucoma, a leading cause of blindness in the United States.
J&J to buy Actelion for $30-billion, spin off R&D unit
This file photo shows the exterior of the headquarters of Swiss biotechnology group Actelion in Allschwil, near Basel. U.S. pharmaceuticals giant Johnson & Johnson on Jan. 26 announced it was buying Swiss medical firm Actelion for $30-billion.
Novavax Inc. (NVAX) Stock Rating Reaffirmed by Cantor Fitzgerald
‘s stock had its “hold” rating restated by research analysts at Cantor Fitzgerald in a research report issued on Friday. They currently have a $2.00 price objective on the biopharmaceutical company’s stock.
Proclaim DRG Dorsal Root Ganglion Neurostimulator for Chronic Pain Released in Europe
St. Jude Medical , now a part of Abbott , is making available in Europe its Proclaim DRG Neurostimulation System. The implant features 4-ports and 16-channels to help control chronic neuropathic pain by electrically stimulating the dorsal root ganglion , a body of neurons responsible for managing pain signals moving up the spine.
Athersys Subsidiary and Leading Animal Health Company Enter Into…
Athersys, Inc. announced today that through its Belgian subsidiary, ReGenesys BVBA , it has entered into an agreement with a global leader in the animal health business segment to evaluate the cell therapy technology for application in a non-disclosed animal health area. Under the terms of the agreement, ReGenesys will receive an initial payment in exchange for an exclusive period to evaluate the cell therapy technology with an option to negotiate for a license for the development and commercialization of the technology for this area.
CPE.H – Capital Pro Egaux Inc.
Capital Pro-Egaux licenses patents to nSequence et al. 2017-01-10 09:21 MT – News Release Mr. Pierre Desormeau reports CAPITAL PRO-EGAUX INC. ANNOUNCES THE CONCLUSION OF A LICENSE AGREEMENT WITH NSEQUENCE CENTER FOR ADVANCED DENTISTRY AND NATIONAL DENTEX CORPORATION Capital Pro-Egaux Inc.’s wholly owned subsidiary, Technique d’usinage Sinlab Inc., has entered into a patent licence agreement with nSequence Center for Advanced Dentistry and National Dentex Corp. As part of the agreement, Sinlab granted licensees a non-exclusive worldwide licence to make, use, sell and offer to sell inventions covered by its patents, including patents relating to its Technobar and Technoguide technologies, under terms undisclosed for confidentiality reasons.
Brokerages Set $6.00 Target Price for Athersys, Inc.
Shares of Athersys, Inc. have earned a consensus broker rating score of 1.00 from the two brokers that provide coverage for the stock, Zacks Investment Research reports. Two analysts have rated the stock with a strong buy rating.
Biden’s Cancer Moonshot Draws on Aussie Nobel-Winning Expertise
U.S. Vice President Joe Biden arrived in Melbourne last July with his granddaughters in tow. Bypassing sporting stadiums and race-car tracks, Biden’s first official stop in the world’s sporting capital was to open a A$1 billion cancer center.
US warns of unusual cybersecurity flaw in heart devices
This Wednesday, July 22, 2015, file photo shows St. Jude Medical corporate headquarters, in Little Canada, Minn., just north of St. Paul. The Homeland Security Department is warning the public about an unusual cybersecurity flaw for one manufacturer’s implantable heart devices that could allow hackers to remotely take control of a person’s defibrillator or pacemaker.
US warns of unusual cybersecurity flaw in heart devices
The Homeland Security Department warned Tuesday about an unusual cybersecurity flaw for one manufacturer’s implantable heart devices that it said could allow hackers to remotely take control of a person’s defibrillator or pacemaker. Information on the security flaw, identified by researchers at MedSec Holdings in reports months ago, was only formally made public after the manufacturer, St. Jude Medical, made a software repair available Monday.
FDA: Cardiac device info vulnerable to hackers
If you used an Optimum login , click the Connect Account button to use your Optimum login info to manage your Newsday subscription account. If you used a Newsday login , it looks like it’s not connected to an active subscriber account.
St. Jude says it’s working to protect pacemakers from hackers :0
Nearly five months after ending up in the crosshairs of a short seller, St. Jude Medical said Monday it’s upgrading its cybersecurity to enhance the safety of its implantable heart devices. The updates come after the Food and Drug Administration found that St. Jude’s heart devices have “vulnerabilities” that could allow hackers to break into pacemakers, resulting in battery depletion or “inappropriate pacing or shocks.”
Biotechs are paying a price for their high drug costs
The biotech industry hit a speed bump in 2016 after logging accelerating growth for years. US drug approvals fell to just 22 – from 45 in 2015 – a six-year low.
Here’s Why Alnylam Pharmaceuticals Plunged 59.8% in 2016
A major clinical setback removed a potential blockbuster drug from Alnylam’s pipeline and led to a collapse in the company’s share price. . Shares of the RNAi-focused biotech utterly collapsed, falling by nearly 60% during the year, according to data from S&P Global Market Intelligence .
Here’s Why Alnylam Pharmaceuticals Plunged 59.8% in 2016
A major clinical setback removed a potential blockbuster drug from Alnylam’s pipeline and led to a collapse in the company’s share price. . Shares of the RNAi-focused biotech utterly collapsed, falling by nearly 60% during the year, according to data from S&P Global Market Intelligence .
Carlyle Said to Explore Sale of Vitamin Maker Nature’s Bounty
Carlyle Group LP is exploring a sale of nutritional-supplements maker Nature’s Bounty Co., whose brands include “MET-Rx” and “Pure Protein,” people with knowledge of the matter said. The private equity firm has held talks with potential advisers about selling the U.S. company, formerly known as NBTY Inc., according to the people.
OncoMed Announces Year-End Cash Balance and 2017 Outlook
OncoMed Pharmaceuticals Inc. , a clinical-stage company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology therapeutics, today pre-announced its 2016 year-end cash balance and reviewed key anticipated events for 2017. OncoMed ended 2016 with approximately $184.6 million in cash.
East/West CEO Conference to Feature Prominent CEOs and Industry Leaders on January 7th & 8th
Join Deborah Dunsire,CEO, Southern Cross Biotech Consulting;Tom Heyman,CEO, Janssen Pharmaceutica;Charlotte Hubbert,Partner, Bill & Melinda Gates Foundation;Emil Kakkis,CEO & President, Ultragenyx;Mathai Mammen,SVP Research, Merck;Geoff McDonough,President & CEO, Sobi;Susan Molineaux,President & CEO, Calithera;Paris Panayiotopoulos,President & CEO, ARIAD;Rob Perez,Founder and Chairman, Life Science Cares;David Pyott,Former CEO, Allergan;Paul Stoffels,CSO, Johnson & Johnson;Henri Termeer, former CEO,Genzyme;J.
Amgen Hikes Dividend By 15%. Is It A Buy, Sell, Or Hold?
Early in the year, I said that Amgen’s dividend growth is likely to slow down . Specifically, this was my reasoning: Amgen has expanded its payout ratio from 7% in 2011 to 40% now.
Neogen Corporation (NEOG) Position Decreased by Rehmann Capital Advisory Group
Rehmann Capital Advisory Group reduced its position in shares of Neogen Corporation by 0.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission . The fund owned 3,882 shares of the company’s stock after selling 17 shares during the period.
Press release distribution, EDGAR filing, XBRL, regulatory filings
After many years serving in d… )–Opus Bank announced today that it completed on December 23, 2016 the securitization of approximately $509 million of its multifamily loans th… )–ALS and AD bioinformatics reports confirm GM6’s role as regulator of disease-relevant pathways.
Press release distribution, EDGAR filing, XBRL, regulatory filings
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Alexion Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 )–Levi & Korsinsky reminds shareholders of a class action lawsuit on behalf of shareholders of Alexion Pharmaceuticals, Inc. who purchased shares between February 10, 2014 … SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of TerraVia Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 )–Levi & Korsinsky reminds shareholders of a class action lawsuit on behalf of shareholders of TerraVia Holdings, Inc. who purchased shares between August 8,… DPLO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Diplomat Pharmacy, Inc. and a Lead Plaintiff Deadline of January 9, 2017 )–The Law Offices of Vincent Wong … (more)
Press release distribution, EDGAR filing, XBRL, regulatory filings
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Alexion Pharmaceuticals, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 )–Levi & Korsinsky reminds shareholders of a class action lawsuit on behalf of shareholders of Alexion Pharmaceuticals, Inc. who purchased shares between February 10, 2014 … SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of TerraVia Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 )–Levi & Korsinsky reminds shareholders of a class action lawsuit on behalf of shareholders of TerraVia Holdings, Inc. who purchased shares between August 8,… DPLO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Diplomat Pharmacy, Inc. and a Lead Plaintiff Deadline of January 9, 2017 )–The Law Offices of Vincent Wong … (more)
Health Care Companies Showing Good Defensive Potential
Among U.S. companies, health care companies offer good defensive-investing opportunities. Such companies, including Johnson & Johnson , Biogen Inc. and VCA Inc. , generally had strong financial strength and gross margins.
Artificial kidney called ‘holy grail’
A video emerged on Tuesday night of Michael Floyd’s DUI arrest in Arizona from last week.
Neogen Corp. (NEOG) Posts Earnings Results, Beats Expectations By $0.02 EPS
Neogen Corp. released its earnings results on Wednesday. The company reported $0.29 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.27 by $0.02.
Neogen Corp. (NEOG) Posts Earnings Results, Beats Expectations By $0.02 EPS
Neogen Corp. released its earnings results on Wednesday. The company reported $0.29 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.27 by $0.02.